Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Applied Therapeutics (APLT) Receivables - Other (2023 - 2025)

Historic Receivables - Other for Applied Therapeutics (APLT) over the last 2 years, with Q3 2025 value amounting to $16.7 million.

  • Applied Therapeutics' Receivables - Other changed N/A to $16.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.7 million, marking a year-over-year change of. This contributed to the annual value of $23000.0 for FY2023, which is N/A changed from last year.
  • As of Q3 2025, Applied Therapeutics' Receivables - Other stood at $16.7 million.
  • In the past 5 years, Applied Therapeutics' Receivables - Other registered a high of $16.7 million during Q3 2025, and its lowest value of $23000.0 during Q1 2023.